These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35443040)

  • 1. D3AI-CoV: a deep learning platform for predicting drug targets and for virtual screening against COVID-19.
    Yang Y; Zhou D; Zhang X; Shi Y; Han J; Zhou L; Wu L; Ma M; Li J; Peng S; Xu Z; Zhu W
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35443040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D3AI-Spike: A deep learning platform for predicting binding affinity between SARS-CoV-2 spike receptor binding domain with multiple amino acid mutations and human angiotensin-converting enzyme 2.
    Han J; Liu T; Zhang X; Yang Y; Shi Y; Li J; Ma M; Zhu W; Gong L; Xu Z
    Comput Biol Med; 2022 Dec; 151(Pt A):106212. PubMed ID: 36327885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based approach for predicting drug targets and for virtual screening against COVID-19.
    Yang Y; Zhu Z; Wang X; Zhang X; Mu K; Shi Y; Peng C; Xu Z; Zhu W
    Brief Bioinform; 2021 Mar; 22(2):1053-1064. PubMed ID: 33461215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
    Wang S; Sun Q; Xu Y; Pei J; Lai L
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases.
    Kumari M; Subbarao N
    Comput Biol Med; 2021 May; 132():104317. PubMed ID: 33721736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
    Talluri S
    Comb Chem High Throughput Screen; 2021; 24(5):716-728. PubMed ID: 32798373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis.
    Nand M; Maiti P; Joshi T; Chandra S; Pande V; Kuniyal JC; Ramakrishnan MA
    Sci Rep; 2020 Nov; 10(1):20397. PubMed ID: 33230180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR Modeling of SARS-CoV M
    Alves VM; Bobrowski T; Melo-Filho CC; Korn D; Auerbach S; Schmitt C; Muratov EN; Tropsha A
    Mol Inform; 2021 Jan; 40(1):e2000113. PubMed ID: 33405340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Li Z; Li X; Huang YY; Wu Y; Liu R; Zhou L; Lin Y; Wu D; Zhang L; Liu H; Xu X; Yu K; Zhang Y; Cui J; Zhan CG; Wang X; Luo HB
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27381-27387. PubMed ID: 33051297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
    Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs.
    Feng Z; Chen M; Xue Y; Liang T; Chen H; Zhou Y; Nolin TD; Smith RB; Xie XQ
    Brief Bioinform; 2021 Mar; 22(2):946-962. PubMed ID: 33078827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19.
    Shi Y; Zhang X; Mu K; Peng C; Zhu Z; Wang X; Yang Y; Xu Z; Zhu W
    Acta Pharm Sin B; 2020 Jul; 10(7):1239-1248. PubMed ID: 32318328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
    Jang WD; Jeon S; Kim S; Lee SY
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
    Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach.
    Indu P; Rameshkumar MR; Arunagirinathan N; Al-Dhabi NA; Valan Arasu M; Ignacimuthu S
    J Infect Public Health; 2020 Dec; 13(12):1856-1861. PubMed ID: 33168456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M
    Tejera E; Munteanu CR; López-Cortés A; Cabrera-Andrade A; Pérez-Castillo Y
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33172092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
    Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
    Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
    Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
    Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.